Diseases, Conditions, Syndromes

Allopurinol linked to reduced risk for CKD stage ≥3 in gout

(HealthDay)—For patients with gout, allopurinol is associated with a reduced risk for developing chronic kidney disease stage ≥3, according to a study published online Oct. 8 in JAMA Internal Medicine.

Diseases, Conditions, Syndromes

Major cardiovascular study of gout patients has unexpected finding

A large study of cardiovascular events in gout patients taking one of two medications to prevent excess build-up of uric acid has found that one of the drugs, febuxostat, increased the risk of death for those with heart disease, ...

Oncology & Cancer

Allopurinol Rx more likely with eligibility at diagnosis

(HealthDay)—Allopurinol prescribing is more likely if patients meet eligibility criteria at diagnosis, according to a research brief published in the November/December issue of the Annals of Family Medicine.

Cardiology

Allopurinol has little benefit in cardiac syndrome X

(HealthDay)—Allopurinol does not appear to improve exercise capacity or peripheral endothelial or coronary function in patients with cardiac syndrome X, according to a study published online Oct. 28 in Cardiovascular Therapeutics.

Arthritis & Rheumatism

Study finds gout drug may reduce risk of death

(Boston)—In a recently to be published study in Annals of the Rheumatic Diseases, researchers have found the use of the drug allopurinol was associated with a reduced risk of death in hyperuricemic (gout) patients. The ...

page 1 from 2